Centre Hospitalier Ardeche Nord
- Address
- lock Available on a paid plan
Centre Hospitalier Ardeche Nord - Renal and Cardiovascular Research
Centre Hospitalier Ardeche Nord is a clinical research facility specializing in advanced kidney disease management and cardiovascular complications. The center demonstrates particular expertise in investigating novel therapeutic interventions for patients with progressive renal dysfunction and associated comorbidities, focusing on slowing disease progression and improving outcomes in complex patient populations.
- Chronic kidney disease (CKD) progression and hypertension management with combination pharmacological therapies
- End-stage kidney disease (ESKD) and dialysis-dependent patient care
- Atherosclerotic cardiovascular disease in advanced renal failure populations
The research program addresses critical gaps in nephrology care, from early-stage CKD with hypertension to ESKD requiring maintenance dialysis. Studies evaluate innovative approaches including combination drug therapies targeting glomerular filtration rate (eGFR) preservation and anti-inflammatory interventions aimed at reducing high-sensitivity C-reactive protein (hs-CRP) levels to mitigate cardiovascular risk in dialysis patients. This comprehensive research approach reflects the center's commitment to addressing the full spectrum of kidney disease and its cardiovascular complications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Ardeche Nord
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of RO7434656, an Antisense Inhibitor of Complement Factor B, in Patients with Primary IgA Nephropathy at High Risk of Progression | F. Hoffmann-La Roche AG | Phase III | Not Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baxdrostat | 1 | Unknown | 2024-06-05 | 2024-06-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.